{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:00:21Z","timestamp":1790794821146,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T00:00:00Z","timestamp":1601769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T00:00:00Z","timestamp":1601769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>During the COVID-19 pandemic, hospitals faced increasing pressure, where people living with HIV risked to either acquire SARS-CoV-2 and to interrupt the HIV continuum of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This is a retrospective, observational study. We compared the numbers of medical visits performed, antiretroviral drugs dispensed and the number of new HIV diagnosis and of hospitalizations in a cohort of people living with HIV (PLWH) followed by the Spedali Civili of Brescia between the bimester of the COVID-19 pandemic peak and the bimester of October\u2013November 2019. Data were retrieved from administrative files and from paper and electronic clinical charts. Categorical variables were described using frequencies and percentages, while continuous variables were described using mean, median, and interquartile range (IQR) values. Means for continuous variables were compared using Student\u2019s t-tests and the Mann\u2013Whitney test. Proportions for categorical variables were compared using the\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      As of December 31st, 2019, a total of 3875 PLWH were followed in our clinic. Mean age was 51.4\u2009\u00b1\u200913\u00a0years old, where 28% were females and 18.8% non-Italian. Overall, 98.9% were on ART (n\u2009=\u20093834), 93% were viro-suppressed. A total of 1217 and 1162 patients had their visit scheduled at our out-patient HIV clinic during the two bimesters of 2019 and 2020, respectively. Comparing the two periods, we observed a raise of missed visits from 5 to 8% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), a reduction in the number of new HIV diagnosis from 6.4 in 2019 to 2.5 per month in 2020 (\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.01), a drop in ART dispensation and an increase of hospitalized HIV patients due to COVID-19\n                      <jats:italic>.<\/jats:italic>\n                      ART regimens including protease inhibitors (PIs) had a smaller average drop than ART not including PIs (16.6 vs 21.6%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Whether this may be due to the perception of a possible efficacy of PIs on COVID19 is not known.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our experience highlights the importance of a resilient healthcare system and the need to implement new strategies in order to guarantee the continuum of HIV care even in the context of emergency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12981-020-00314-y","type":"journal-article","created":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T13:02:34Z","timestamp":1601816554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy"],"prefix":"10.1186","volume":"17","author":[{"given":"Eugenia","family":"Quiros-Roldan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7660-161X","authenticated-orcid":false,"given":"Paola","family":"Magro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canio","family":"Carriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annacarla","family":"Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"El Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tratta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Fazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Formenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,4]]},"reference":[{"key":"314_CR1","unstructured":"WHO announces COVID-19 outbreak a pandemic (Internet). 2020. https:\/\/www.euro.who.int\/en\/health-topics\/health-emergencies\/coronavirus-covid-19\/news\/news\/2020\/3\/who-announces-covid-19-outbreak-a-pandemic. Accessed 2 May 2020."},{"key":"314_CR2","unstructured":"Covid-19 - Situazione in Italia (Internet). 2020. https:\/\/www.salute.gov.it\/portale\/nuovocoronavirus\/dettaglioContenutiNuovoCoronavirus.jsp?area=nuovoCoronavirus&id=5351&lingua=italiano&menu=vuoto. Accessed 2 May 2020."},{"key":"314_CR3","unstructured":"UN Joint Programme on HIV\/AIDS (UNAIDS). 90-90-90. An ambitious treatment target to help end the AIDS epidemic. United Nations. 2014. https:\/\/www.unaids.org\/en\/resources\/909090. Accessed May 2020."},{"key":"314_CR4","unstructured":"Covid 19 - Ripartizione dei contagiati per provincia (Internet). 2020. https:\/\/www.salute.gov.it\/imgs\/C_17_notizie_4659_1_file.pdf. Accessed 2 May 2020."},{"issue":"1","key":"314_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15284336.2019.1595887","volume":"20","author":"A Comelli","year":"2019","unstructured":"Comelli A, Izzo I, Donato F, Celotti A, Foca E, Pezzoli C, et al. Disengagement and reengagement of HIV continuum of care in a single center cohort in northern Italy. HIV Res Clin Pract. 2019;20(1):1\u201311.","journal-title":"HIV Res Clin Pract"},{"key":"314_CR6","unstructured":"Regione Lombardia Direzione Generale Welfare. Percorso diagnostico-terapeutico assistenziale (PDTA) del paziente affetto da malattia HIV\/AIDS. Anno 2019. (Internet). 2019. https:\/\/www.simit.org\/medias\/1505-pdta-hiv-2019.pdf. Accessed 2 May 2020."},{"key":"314_CR7","unstructured":"Istituto Superiore di Sanit\u00e0. Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 dicembre 2018. 2019. https:\/\/old.iss.it\/binary\/publ\/cont\/AGGIORNAMENTO_HIV_2018.pdf. Accessed May 2020."},{"key":"314_CR8","unstructured":"DECRETO DEL PRESIDENTE DEL CONSIGLIO DEI MINISTRI 8 marzo 2020. Ulteriori disposizioni attuative del decreto-legge 23 febbraio 2020, n. 6, recante misure urgenti in materia di contenimento e gestione dell\u2019emergenza epidemiologica da COVID-19. (20A01522) ( (Internet). https:\/\/www.gazzettaufficiale.it\/eli\/id\/2020\/03\/08\/20A01522\/sg. Accessed May 2020."},{"key":"314_CR9","unstructured":"Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. Lancet HIV (Internet). https:\/\/www.thelancet.com\/journals\/lanhiv\/article\/PIIS2352-3018(20)30105-3\/fulltext. Accessed 2 May 2020."},{"key":"314_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02893-3","author":"RM Pinto","year":"2020","unstructured":"Pinto RM, Park S. COVID-19 pandemic disrupts HIV continuum of care and prevention: implications for research and practice concerning community-based organizations and frontline providers. AIDS Behav. 2020. https:\/\/doi.org\/10.1007\/s10461-020-02893-3.","journal-title":"AIDS Behav"},{"issue":"5","key":"314_CR11","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/S2352-3018(20)30110-7","volume":"7","author":"J Hargreaves","year":"2020","unstructured":"Hargreaves J, Davey C, the Group for lessons from pandemic HIV prevention for the COVID-19 response. Three lessons for the COVID-19 response from pandemic HIV. Lancet HIV. 2020;7(5):e309\u2013e311311.","journal-title":"Lancet HIV"},{"key":"314_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02905-2","author":"JP Ridgway","year":"2020","unstructured":"Ridgway JP, Schmitt J, Friedman E, et al. HIV care continuum and COVID-19 outcomes among people living with HIV during the COVID-19 pandemic, Chicago IL. AIDS Behav. 2020. https:\/\/doi.org\/10.1007\/s10461-020-02905-2.","journal-title":"yAIDS Behav"},{"issue":"1","key":"314_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5582\/bst.2020.01020","volume":"14","author":"H Lu","year":"2020","unstructured":"Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020;14(1):69\u201371. https:\/\/doi.org\/10.5582\/bst.2020.01020 (Epub 2020 Jan 28).","journal-title":"Biosci Trends"},{"key":"314_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2020.02.008","author":"C Wu","year":"2020","unstructured":"Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"314_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","volume":"6","author":"C Liu","year":"2020","unstructured":"Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ, et al. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases. ACS Cent Sci. 2020;6(3):315\u201331.","journal-title":"ACS Cent Sci"},{"key":"314_CR16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.csbj.2020.03.025","volume":"18","author":"BR Beck","year":"2020","unstructured":"Beck BR, Shin B, Choi Y, Park S, Kang K. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Comput Struct Biotechnol J. 2020;18:784\u201390.","journal-title":"Comput Struct Biotechnol J"},{"issue":"5","key":"314_CR17","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1016\/S2352-3018(20)30111-9","volume":"7","author":"JL Blanco","year":"2020","unstructured":"Blanco JL, Ambrosioni J, Garcia F, Mart\u00ednez E, Soriano A, Mallolas J, Miro JM, COVID-19 in HIV Investigators. COVID-19 in patients with HIV: clinical case series. Lancet HIV. 2020;7(5):e314\u2013e316316. https:\/\/doi.org\/10.1016\/S2352-3018(20)30111-9 (Epub 2020 Apr 15).","journal-title":"Lancet HIV"},{"key":"314_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa579","author":"C Gervasoni","year":"2020","unstructured":"Gervasoni C, Meraviglia P, Riva A, Giacomelli A, Oreni L, Minisci D, et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa579 (Epub ahead of print).","journal-title":"Clin Infect Dis"},{"issue":"19","key":"314_CR19","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020;382(19):1787\u201399. https:\/\/doi.org\/10.1056\/NEJMoa2001282.","journal-title":"N Engl J Med"},{"issue":"157","key":"314_CR20","doi-asserted-by":"publisher","first-page":"104826","DOI":"10.1016\/j.phrs.2020.104826","volume":"20","author":"A Riva","year":"2020","unstructured":"Riva A, Conti F, Bernacchia D, Pezzati L, Sollima S, Merli S, Siano M, Lupo A, Rusconi S, Cattaneo D, Gervasoni C. Darunavir does not prevent SARS-CoV-2 infection in HIV patients. Pharmacol Res. 2020;20(157):104826. https:\/\/doi.org\/10.1016\/j.phrs.2020.104826 (Epub ahead of print).","journal-title":"Pharmacol Res."},{"key":"314_CR21","unstructured":"Lu H. Efficacy and safety of darunavir and cobicistat for treatment of COVID-19 (DC-COVID-19) (Internet). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04252274#wrapper. Accessed May 2020."},{"key":"314_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30139-9","author":"R Jones","year":"2020","unstructured":"Jones R, Nelson M, Bracchi M, Asboe D, Boffito M. COVID-19 in patients with HIV. Lancet HIV. 2020. https:\/\/doi.org\/10.1016\/S2352-3018(20)30139-9 (Epub ahead of print).","journal-title":"Lancet HIV"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00314-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-020-00314-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-020-00314-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T12:58:44Z","timestamp":1633352324000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-020-00314-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,4]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["314"],"URL":"https:\/\/doi.org\/10.1186\/s12981-020-00314-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-38253\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-38253\/v2","asserted-by":"object"}]},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,4]]},"assertion":[{"value":"29 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FC reports acting as a principle investigator of company-sponsored clinical trials in the field of HIV infection (ViiV Healthcare, GlaxoSmithKline, Gilead Sciences and Janssen \u2013 Cilag). EQR. received travel grants from Bristol-Myers Squibb, Gilead Sciences, ViiV Healthcare, Janssen-Cilaq Merck Sharp & Dohme and consultancy fees from Janssen -Cilag, ViiV Healthcare and Merck Sharp & Dohme. The other authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}